tirzepatide health risks Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Tirzepatide for Medical Weight Loss

Do not flush semaglutide

Gastroenterology 104 , 13711380 (1993)

What the Science Says According to the STEP 1 trial, which led to semaglutide's FDA approval for weight loss, participants who combined medication with increased physical activity lost significantly more weight

This case report presents a 70-year-old patient who developed pleural and pericardial effusions likely related to semaglutide use

In Dallas, patients have ditched surgical weight loss and medical supervision in favor of once-weekly injections that seemingly melt off weight

What remains, however, is why there appears to be ample supply for Wegovy, the same ingredient, but the Ozempic supply remains compromised until further notice